Stocktoria
CVRx, Inc. CVRX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-06-30
CVRx, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $56.7M | $51.3M | $39.3M | $22.5M | $13.0M |
| Gross profit | $48.3M | $43.0M | $33.0M | $17.5M | $9.4M |
| R&D expense | $11.1M | $11.1M | $11.6M | $10.0M | $7.5M |
| SG&A expense | $88.5M | $91.3M | $64.5M | $50.0M | $27.9M |
| Operating income | -$51.3M | -$59.5M | -$43.1M | -$42.5M | -$26.0M |
| Interest expense | — | — | $1.8M | $165,000 | $2.2M |
| Income tax | -$18,000 | $55,000 | $147,000 | $109,000 | $91,000 |
| Net income | -$53.3M | -$60.0M | -$41.2M | -$41.4M | -$43.1M |
| EPS (diluted) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 |
| Operating cash flow | -$40.2M | -$39.1M | -$39.0M | -$42.7M | -$27.7M |
| Free cash flow | -$40.8M | -$40.5M | -$39.6M | -$43.4M | -$28.9M |
| Cash & equivalents | $75.7M | $105.9M | $90.6M | $106.2M | $142.1M |
| Inventory | $12.2M | $12.1M | $11.0M | $7.0M | $3.9M |
| Total assets | $104.8M | $133.4M | $115.2M | $124.9M | $152.5M |
| Total liabilities | $65.5M | $62.4M | $39.3M | $15.8M | $6.6M |
| Shareholders' equity | $39.3M | $71.1M | $75.9M | $109.2M | $146.0M |
Source: SEC EDGAR filings · CIK 0001235912 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.